Maia Pharms Inc Drug Patent Portfolio
Maia Pharms Inc owns 3 orange book drugs protected by 9 US patents Given below is the list of Maia Pharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11679119 | Bortezomib compositions | 23 Sep, 2042 | Active |
| US11752164 | Bortezomib compositions | 23 Sep, 2042 | Active |
| US12005069 | Bortezomib compositions | 23 Sep, 2042 | Active |
| US11903993 | Ready-to-use bivalirudin compositions | 20 May, 2039 | Active |
| US11918622 | Ready-to-use bivalirudin compositions | 20 May, 2039 | Active |
| US11992514 | Ready-to-use bivalirudin compositions | 20 May, 2039 | Active |
| US11110063 | Storage stable sincalide formulations | 20 Apr, 2038 | Active |
| US11318100 | Storage stable sincalide formulations | 20 Apr, 2038 | Active |
| US11737983 | Storage stable sincalide formulations | 20 Apr, 2038 | Active |
Latest Legal Activities on Maia Pharms Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Maia Pharms Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Sequence Moved to Public Database | 15 Mar, 2024 | US11918622 |
| Patent eGrant Notification | 05 Mar, 2024 | US11918622 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Mar, 2024 | US11918622 |
|
Recordation of Patent Grant Mailed
Critical
| 05 Mar, 2024 | US11918622 |
|
Email Notification
Critical
| 05 Mar, 2024 | US11918622 |
| Recordation of Patent eGrant | 05 Mar, 2024 | US11918622 |
| Mail Patent eGrant Notification | 05 Mar, 2024 | US11918622 |
| Sequence Moved to Public Database | 29 Feb, 2024 | US11903993 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Feb, 2024 | US11903993 |
| Mail Patent eGrant Notification | 20 Feb, 2024 | US11903993 |
| Patent eGrant Notification | 20 Feb, 2024 | US11903993 |
|
Email Notification
Critical
| 20 Feb, 2024 | US11903993 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Feb, 2024 | US11903993 |
| Recordation of Patent eGrant | 20 Feb, 2024 | US11903993 |
|
Email Notification
Critical
| 15 Feb, 2024 | US11918622 |
Maia Pharms Inc's Family Patents
Maia Pharms Inc Drug List
Given below is the complete list of Maia Pharms Inc's drugs and the patents protecting them.
1. Angiomax Rtu
Angiomax Rtu is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11903993 | Ready-to-use bivalirudin compositions |
20 May, 2039
(14 years from now)
| Active |
| US11918622 | Ready-to-use bivalirudin compositions |
20 May, 2039
(14 years from now)
| Active |
| US11992514 | Ready-to-use bivalirudin compositions |
20 May, 2039
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Angiomax Rtu's drug page
2. Bortezomib
Bortezomib is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11679119 | Bortezomib compositions |
23 Sep, 2042
(17 years from now)
| Active |
| US11752164 | Bortezomib compositions |
23 Sep, 2042
(17 years from now)
| Active |
| US12005069 | Bortezomib compositions |
23 Sep, 2042
(17 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Bortezomib's drug page
3. Sincalide
Sincalide is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11110063 | Storage stable sincalide formulations |
20 Apr, 2038
(12 years from now)
| Active |
| US11318100 | Storage stable sincalide formulations |
20 Apr, 2038
(12 years from now)
| Active |
| US11737983 | Storage stable sincalide formulations |
20 Apr, 2038
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sincalide's drug page